对于非专家而言,轻链心肌粉症:珍珠和陷
Laura De Michieli1, Giulio Sinigiani2, Monica De Gaspari2,3
1Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy. laura.demichieli@phd.unipd.it.
Internal and emergency medicine
|June 20, 2023
概括
诊断心脏粉症 (CA),特别是轻链CA (AL-CA),需要仔细考虑诊断测试. 骨光学或脂肪活检的负结果并不排除AL-CA,需要进一步的血液学评估.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 病理学 病理学 病理学
背景情况:
- 心脏粉症 (CA) 是一种罕见的,渐进的,往往致命的疾病.
- 轻链CA (AL-CA) 是一种医疗紧急情况,诊断延迟显著恶化了患者的结果.
- 及时和准确的诊断对于有效管理AL-CA至关重要.
研究的目的:
- 突出诊断的关键挑战和潜在的陷在识别心脏粉样性粉症,特别是AL-CA.
- 强调避免AL-CA诊断和治疗延迟的重要性.
- 从临床病例提供见解,以提高诊断准确度.
主要方法:
- 对三种临床病例的审查,这些病例在心脏粉样化症中提出了诊断挑战.
- 分析诊断方法的实用性和局限性,包括骨光学,脂肪活检和刚果红色染色.
- 强调需要特定的粉样纤维类型的方法.
主要成果:
- 阴性骨光扫描并不能排除CA;AL-CA患者可能显示心脏吸收最小,此测试不应延迟血液学评估.
- 脂肪活检对AL Amyloidosis的敏感度不是100%;如果结果是负的,并且前测试概率很高,则需要进一步调查.
- 刚果红色染色单独是不够的; 确定的诊断需要通过质谱,免疫组织化学或免疫电子显微镜对粉样纤维的类型进行定型.
结论:
- 准确诊断心肌粉症,特别是AL-CA,需要一个全面的方法,整合各种诊断工具.
- 意识到常见的诊断测试的局限性,如骨光学和脂肪活检至关重要.
- 使用先进的粉样类型识别技术对于确认AL-CA和指导治疗决策至关重要.
相关概念视频
03:03Amyloid Fibrils
5.5K
5.5K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:25Cardiomyopathy I: Introduction and Classification
22
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
22
01:29Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
22
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22